Eyenovia Inc (EYEN)
followers
·
Follow
1 like
| Sector: | HEALTH CARE |
| Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Michael M. Rowe |
| Employees: | 40 |
| Web site: | eyenovia.com |
|
295 MADISON AVENUE,, SUITE 2400, NEW YORK, NY, 10017
813-766-9539
| |
| Date | Ratio |
|---|---|
| 2025-02-03 | 1:80 |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Eyenovia, Inc. engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. Its product candidates include MicroLine, MicroPine and MydCombi.
Please log in first to see chart